Overcoming Resistance to the First Generation of G12C Inhibitors to Increase Patient Response Rates
Time: 11:00 am
day: Day One Track B AM
Details:
- Assessing the observed resistance mechanisms against G12C inhibitors in the clinic and beyond
- Creating actionable insights to overcome resistance and increase the effectiveness of RAS therapies
- Devising strategies from the current learnings to improve patient response to RAS drugs in future trials
